Potential predictors of disease progression for main‐duct intraductal papillary mucinous neoplasms of the pancreas

T Ogura, D Masuda, Y Kurisu… - Journal of …, 2013 - Wiley Online Library
Abstract Background and Aim The evidence for main pancreatic duct intraductal papillary
mucinous neoplasms (MPD‐IPMN) malignancy is based predominantly on investigation of …

Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9 mm

T Hackert, S Fritz, M Klauss, F Bergmann… - Annals of …, 2015 - journals.lww.com
Objective: The 2012 international consensus guidelines for the management of intraductal
papillary mucinous neoplasms (IPMN) recommend surgical treatment in main-duct IPMN …

Predictors of malignancy and natural history of main-duct intraductal papillary mucinous neoplasms of the pancreas

K Takuma, T Kamisawa, H Anjiki, N Egawa, M Kurata… - Pancreas, 2011 - journals.lww.com
Objectives: Because the prevalence of carcinoma is high in main-duct intraductal papillary
mucinous neoplasms (IPMNs) of the pancreas, surgical resection is recommended for all …

Prediction of malignancy in main duct or mixed‐type intraductal papillary mucinous neoplasms of the pancreas

HS Jung, Y Han, JS Kang, H Sohn… - Journal of Hepato …, 2022 - Wiley Online Library
Abstract Background/Purpose Surgical indications of main duct‐involved intraductal
papillary mucinous neoplasm (IPMN), especially for main pancreatic duct (MPD) of 5‐9 mm …

Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: duct diameter of less than 10 mm and segmental dilatation of …

TH Kim, TJ Song, SO Lee, CH Park, JH Moon, GY Pih… - Pancreatology, 2019 - Elsevier
Objective The guidelines for pancreatic intraductal papillary mucinous neoplasms (IPMNs)
recommend surgical resection of all main-duct (MD) and mixed-type IPMNs in surgically fit …

Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms

K Abdeljawad, KC Vemulapalli, CM Schmidt… - Gastrointestinal …, 2014 - Elsevier
Background Risk of malignancy in main duct intraductal papillary mucinous neoplasm (MD-
IPMN) ranges from 36% to 100% in the literature. Although surgical resection is …

[HTML][HTML] Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas

M Daudé, F Muscari, C Buscail, N Carrère… - World Journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To compare characteristics and outcomes of resected and nonresected main-duct and
mixed intraductal papillary mucinous neoplasms of the pancreas (IPMN). METHODS: Over a …

IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection

G Marchegiani, M Mino-Kenudson, K Sahora… - Annals of …, 2015 - journals.lww.com
Objectives: To describe the characteristics of intraductal papillary mucinous neoplasms
(IPMNs) with predominant involvement of the main pancreatic duct (MPD), analyzing …

A natural course of main duct intraductal papillary mucinous neoplasm of the pancreas with lower likelihood of malignancy

H Uehara, O Ishikawa, K Ikezawa, N Kawada, T Inoue… - Pancreas, 2010 - journals.lww.com
Objectives: Main duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas
include neoplasms with varying likelihood of progression to malignancy. The aim of this …

Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy …

BL Ecker, SM Dickinson, LV Saadat, AJ Tao… - Annals of …, 2023 - journals.lww.com
Objective: To determine whether the morphologic features of the main pancreatic duct
(MPD) of main-duct-involved-intraductal papillary mucinous neoplasm (IPMN)(ie, main duct …